Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical formulations and compositions of a selective antagonist of either CXCR2 or both CXCR1 and CXCR2 and methods of using the same for treating inflammatory disorders

Pharmaceutical formulations and compositions of a selective antagonist of either CXCR2 or both CXCR1 and CXCR2 and methods of using the same for treating inflammatory disorders

US Patent 8183287 · Granted May 22, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination decitabine and cedazuridine solid oral dosage forms2025
Combination decitabine and cedazuridine solid oral dosage forms2024
Controlled release formulations of levodopa and uses thereof2018
Controlled release formulations of levodopa and uses thereof2017
Controlled release formulations of levodopa and uses thereof2016
Controlled release formulations of levodopa and uses thereof2015
Controlled release formulations of levodopa and uses thereof2015
Sublingual buccal effervescent2014
Transmucosal effervescent2014
Sublingual buccal effervescent2014
Sublingual buccal effervescent2014
Controlled release formulations of levodopa and uses thereof2013